MedPath

Efficacy and safety of Sofosbuvir and Velpatasvir for Japanese patients with HCV related hepatitis in real-world setting

Not Applicable
Recruiting
Conditions
chronic hepatitis C patients with or without compensated cirrhosis
Registration Number
JPRN-UMIN000050842
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion Criteria 1.Patients who are judged by the research lead to be inappropriate for participation in this review 2.Other persons who are judged by the principal investigator to be inappropriate as research subjects *Patients who discontinue treatment due to adverse drug reactions, etc. will not be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath